Pediatric HIV-1 in Kenya: pattern and correlates of viral load and association with mortality

Elizabeth Maleche Obimbo1, Dalton Wamalwa, Barbara Richardson

  • 1Department of Pediatrics, University of Nairobi, Nairobi, Kenya.

Insights

Infants infected with HIV-1 after one month of age had better viral control. Maternal viral load predicted infant viral load, which is linked to early mortality in children.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Immunology

Background:

  • Limited data exists on viral replication patterns in vertically HIV-1-infected children in resource-limited settings.
  • Understanding these patterns is crucial for improving outcomes.

Purpose of the Study:

  • To investigate the pattern and correlates of human immunodeficiency virus type 1 (HIV-1) replication in vertically infected children.
  • To determine the role of viral replication on child outcomes up to 24 months of age.

Main Methods:

  • Longitudinal follow-up of 85 HIV-1-infected infants from birth to 24 months.
  • Comparison of serial HIV-1 RNA levels based on timing of infection (in utero, peripartum, late postnatal).
  • Determination of cofactors for viral peak, set point, and mortality.

Main Results:

  • Infants infected after 1 month had significantly lower HIV-1 viral load set points compared to those infected earlier (P = 0.01).
  • Maternal viral load strongly correlated with peak infant viral load (P < 0.001).
  • Low CD4% at 6 months (<15%) independently predicted mortality (HR = 4.85).

Conclusions:

  • Later postnatal HIV-1 infection (after 1 month) is associated with better viral containment.
  • Maternal viral load is a key predictor of infant viral load.
  • Infant viral load and immune status are critical determinants of early mortality in vertically HIV-1-infected children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...